Prosecution Insights
Last updated: May 29, 2026

Examiner: BOECKELMAN, JACOB A

Tech Center 1600 • Art Units: 1628 1655

This examiner grants 36% of resolved cases

Performance Statistics

36.1%
Allow Rate
-23.9% vs TC avg
338
Total Applications
+46.3%
Interview Lift
1134
Avg Prosecution Days
Based on 241 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
3.5%
§102 Novelty
85.0%
§103 Obviousness
3.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17920699 BOWEL MOVEMENT IMPROVING COMPOSITION COMPRISING TENEBRIONIDAE LARVA EXTRACT Non-Final OA CJ CHEILJEDANG CORPORATION
19260073 PLANT-DERIVED COMPOSITIONS THAT MODULATE CELLULAR IMMUNITY Non-Final OA 4Life Patents, LLC
17621858 USE OF A HYDRO-ALCOHOLIC EXTRACT OF EVENING PRIMROSE FOR HYDRATING SKIN AND INCREASING BARRIER FUNCTION Final Rejection L'OREAL
17596513 USE OF WHEY PROTEIN MICELLES FOR CONTROLLING POSTPRANDIAL GLUCOSE RESPONSE Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
17261168 Engineered Exosomes for Medical Applications Final Rejection THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
18449980 COMPOSITIONS AND METHODS UTILIZING SOUTHERN OCEAN MACKEREL OIL FOR PROVIDING HEALTH BENEFITS IN AN ANIMAL Non-Final OA Société des Produits Nestlé S.A.
17665037 AUTOLOGOUS THYMIC TISSUE TRANSPLANTATION Final Rejection UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
17990195 METHODS AND COMPOSITIONS TO CONTROL CELLULAR EXPRESSION Non-Final OA UNIVERSITY OF WYOMING
18368040 ANTIMICROBIAL AGENTS DERIVED FROM BACILLUS Non-Final OA The state of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
18523442 METHODS OF TREATING LEUKEMIA Non-Final OA Mor Research Applications Ltd.
17735956 EDIBLE AERIAL MYCELIA AND METHODS OF MAKING THE SAME Final Rejection Ecovative LLC
18097509 PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE Non-Final OA National Yang Ming Chiao Tung University
18664854 SKIN CARE FORMULATION Non-Final OA MARY KAY INC.
18456798 COMPOSITION FOR INHIBITING WRINKLE Non-Final OA KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
18344828 METHOD FOR PREPARING A FEEDING INSTANT ASTRAGALUS POLYSACCHARIDE POWDER AND APPLICATION THEREOF Non-Final OA ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY
16963845 IMPROVED METHOD FOR PRODUCING HIGH-QUALITY BLOOD MEAL Final Rejection Tessenderlo Group NV
18380875 METHOD FOR EXTRACTING AND PURIFYING TOTAL FLAVONOIDS FROM CARTHAMUS TINCTORIUS L. LEAF (TFFCL), AND USE THEREOF Non-Final OA Shaanxi University of Chinese Medicine
18415498 RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS Non-Final OA Hofseth Biocare ASA
18046503 TRADITIONAL CHINESE MEDICINE-BASED AGENT FOR CACHEXIA PREVENTION AND TREATMENT Final Rejection CHINA MEDICAL UNIVERSITY
18557828 USE OF THERAPEUTIC PLASMA EXCHANGE AND LOW VOLUME PLASMA EXCHANGE FOR THE TREATMENT OF A COGNITIVE IMPAIRMENT Non-Final OA GRIFOLS WORLDWIDE OPERATIONS LIMITED
18565037 PAIN RELIEF COMPOSITION Non-Final OA TO BETTER DAYS LIMITED
18516756 Cordyceps Militaris Designated as Strain M2-105-04, Compositions, Methods of Making, Methods of Using and Methods for Treating Mammals Non-Final OA M2 Ingredients, Inc.
18514277 STORAGE SOLUTIONS FOR MAINTAINING OF AXONAL VIABILITY Non-Final OA David M. JACKSON
18561963 TRADITIONAL CHINESE MEDICINE COMPOSITION FOR INFECTIOUS DISEASE RECOVERY AND USE THEREOF Non-Final OA CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.
16301162 PREBIOTIC COSMETIC COMPOSITIONS AND USE OF THE PREBIOTIC COSMETIC COMPOSITIONS Non-Final OA Natura Cosméticos S.A.
18387769 METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE Non-Final OA SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD.
17668511 NEOCARTILAGE CONSTRUCTS USING UNIVERSAL CELLS Non-Final OA Ocugen, Inc.
18489064 METHOD FOR ALLEVIATING DRY EYE DISEASE Non-Final OA BioRay Biotech. Co., Ltd.
17908465 Methods of Treating Cancer Using Checkpoint Inhibitors in Combination with Purine Cleaving Enzymes Final Rejection Children's Healthcare of Atlanta, Inc.
18466461 HERBAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY Final Rejection Spoke Sciences, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month